BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 34090979)

  • 1. Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory Syndrome.
    Lamrani L; Manlhiot C; Elias MD; Choueiter NF; Dionne A; Harahsheh AS; Portman MA; McCrindle BW; Dahdah N
    Can J Cardiol; 2021 Oct; 37(10):1619-1628. PubMed ID: 34090979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children mimicking Kawasaki disease.
    Mercier JC; Ouldali N; Melki I; Basmaci R; Levy M; Titomanlio L; Beyler C; Meinzer U
    Arch Cardiovasc Dis; 2021 May; 114(5):426-433. PubMed ID: 34052147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
    Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A;
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki disease.
    Zhou C; Zhao Y; Wang X; Huang Y; Tang X; Tang L
    Pediatr Pulmonol; 2021 Dec; 56(12):3688-3698. PubMed ID: 34583417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2.
    Yeo WS; Ng QX
    Med Hypotheses; 2020 Nov; 144():110263. PubMed ID: 33254568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
    Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
    Front Immunol; 2021; 12():632890. PubMed ID: 33732254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kawasaki Disease Shock Syndrome in Japan and Comparison With Multisystem Inflammatory Syndrome in Children in European countries.
    Suzuki J; Abe K; Matsui T; Honda T; Yasukawa K; Takanashi JI; Hamada H
    Front Pediatr; 2021; 9():625456. PubMed ID: 33816399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Clinical Features and Inflammatory Markers between Kawasaki Disease Shock Syndrome and Kawasaki Disease without Shock: A Meta-Analysis.
    Zhang H; Zheng Q; Li F
    J Healthc Eng; 2021; 2021():1486089. PubMed ID: 34966519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kawasaki disease shock syndrome in the COVID-19 pandemic.
    Gámez-González LB; Ramírez-López MJ; Colmenero-Rascón M; Yamazaki-Nakashimada MA
    Cardiol Young; 2022 Mar; 32(3):506-507. PubMed ID: 34278987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease shock syndrome: case reports and literature review.
    Lee S; Kim D; Kim BJ; Rhim JW; Lee SY; Jeong DC
    J Rheum Dis; 2023 Oct; 30(4):272-277. PubMed ID: 37736588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort.
    Pouletty M; Borocco C; Ouldali N; Caseris M; Basmaci R; Lachaume N; Bensaid P; Pichard S; Kouider H; Morelle G; Craiu I; Pondarre C; Deho A; Maroni A; Oualha M; Amoura Z; Haroche J; Chommeloux J; Bajolle F; Beyler C; Bonacorsi S; Carcelain G; Koné-Paut I; Bader-Meunier B; Faye A; Meinzer U; Galeotti C; Melki I
    Ann Rheum Dis; 2020 Aug; 79(8):999-1006. PubMed ID: 32527868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
    Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M
    Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
    Cherqaoui B; Koné-Paut I; Yager H; Bourgeois FL; Piram M
    Rheumatology (Oxford); 2021 Oct; 60(10):4530-4537. PubMed ID: 33493353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
    Zhang QY; Xu BW; Du JB
    World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations of Kawasaki disease shock syndrome: a case-control study.
    Chen PS; Chi H; Huang FY; Peng CC; Chen MR; Chiu NC
    J Microbiol Immunol Infect; 2015 Feb; 48(1):43-50. PubMed ID: 23927822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarities and Differences between Multisystem Inflammatory Syndrome in Children (MIS-C) and Kawasaki Disease Shock Syndrome.
    Lee J; Kim BJ; Cho KS; Rhim JW; Lee SY; Jeong DC
    Children (Basel); 2023 Sep; 10(9):. PubMed ID: 37761488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
    Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
    Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.
    Marzano AV; Cassano N; Moltrasio C; Verdoni L; Genovese G; Vena GA
    Dermatology; 2022; 238(1):35-43. PubMed ID: 34062530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases.
    Noval Rivas M; Arditi M
    Rheum Dis Clin North Am; 2023 Aug; 49(3):647-659. PubMed ID: 37331738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.